Autolus Therapeutics

Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Aldeyra Therapeutics
Autolus Therapeutics
Bavarian Nordic
BioXcel Therapeutics
Disc Medicine
Editas Medicine
Immunogen
Lantheus
Mersana Therapeutics
NGM Biopharmaceuticals
Omeros
Roche
Sutro BioPharma
uniQure
Valneva
Viking Therapeutics
Moderna says yes to Autolus, licensing targeting technology for immuno-oncology project
Fierce Biotech
Wed, 10/12/22 - 10:53 am
Moderna Therapeutics
Autolus Therapeutics
MRNA
immuno-oncology
Blackstone continues biotech push with up to $250M cell therapy investment
BioPharma Dive
Mon, 11/8/21 - 10:56 am
funding
Blackstone
Autolus Therapeutics
cwell therapy
obe-cel
Moderna Bolsters mRNA Oncology Business with Autolus' Proprietary Binders
BioSpace
Tue, 08/3/21 - 10:54 am
Autolus Therapeutics
Moderna Therapeutics
RNA
cancer
Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program
Endpoints
Wed, 01/6/21 - 10:58 am
Autolus Therapeutics
ESMO
CAR-T
diffuse large B-cell lymphoma
layoffs
3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting
Motley Fool
Wed, 10/9/19 - 10:25 am
SITC
cancer immunotherapy
Autolus Therapeutics
Mirati Therapeutics
Nektar Therapeutics
Autolus drags on Arix after weak period for CAR-T player
Fierce Biotech
Wed, 08/28/19 - 10:54 am
Autolus Therapeutics
CAR-T
Arix Bioscience